日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Safety, tolerability, and preliminary efficacy of seltorexant versus quetiapine extended release as adjunctive therapy in major depressive disorder: a randomized, flexible-dose, 6-month, parallel-group, exploratory study

塞托雷生与喹硫平缓释片作为重度抑郁症辅助治疗的安全性、耐受性和初步疗效:一项随机、灵活剂量、6个月、平行组、探索性研究

Pinter, Christine; Thase, Michael E; McIntyre, Roger S; Cooper, Kimberly; Xu, Haiyan; Pandina, Gahan; Savitz, Adam; Drevets, Wayne C

Esketamine Nasal Spray: Mechanism of Action, Clinical, and Translational Science

艾司氯胺酮鼻喷雾剂:作用机制、临床和转化科学

van Hoogdalem, Matthijs W; Fu, Dong-Jing; Drevets, Wayne C; Zannikos, Peter N

Esketamine Monotherapy in Adults With Treatment-Resistant Depression: A Randomized Clinical Trial

艾司氯胺酮单药治疗成人难治性抑郁症:一项随机临床试验

Janik, Adam; Qiu, Xin; Lane, Rosanne; Popova, Vanina; Drevets, Wayne C; Canuso, Carla M; Macaluso, Matthew; Mattingly, Gregory W; Shelton, Richard C; Zajecka, John M; Fu, Dong-Jing

Efficacy and Safety of Seltorexant in Insomnia Disorder: A Randomized Clinical Trial

塞托雷生治疗失眠症的疗效和安全性:一项随机临床试验

Mesens, Sofie; Krystal, Andrew D; Melkote, Rama; Xu, Haiyan; Pandina, Gahan; Saoud, Jay B; Luthringer, Remy; Savitz, Adam; Drevets, Wayne C

Treatment effect and safety of seltorexant as monotherapy for patients with major depressive disorder: a randomized, placebo-controlled clinical trial

塞托雷生单药治疗重度抑郁症患者的疗效和安全性:一项随机、安慰剂对照临床试验

Mesens, Sofie; Kezic, Iva; Van Der Ark, Peter; Etropolski, Mila; Pandina, Gahan; Benes, Heike; Savitz, Adam; Drevets, Wayne C

Advancing precision psychiatry and targeted treatments: Insights from immunopsychiatry

推进精准精神病学和靶向治疗:来自免疫精神病学的启示

Miller, Andrew H; Berk, Michael; Bloch, Gilles; Briquet-Laugier, Veronique; Brouillon, Carinne; Cuthbert, Bruce N; Dantzer, Robert; Davis, Michael C; De Picker, Livia J; Drevets, Wayne C; Eyre, Harris A; Hack, Laura M; Harrison, Neil A; Krystal, Andrew D; Lombardo, Giulia; Mondelli, Valeria; Pariante, Carmine M; Pulvirenti, Luigi; Salvadore, Giacomo; Sforzini, Luca; Swieboda, Pawel; Trivedi, Madhukar H; Leboyer, Marion

Towards Enhancing Drug Development Methodology to Treat Cognitive Impairment Associated With Schizophrenia and Other Neuropsychiatric Conditions: Insights From 2 Decades of Clinical Trials

提高治疗精神分裂症及其他神经精神疾病相关认知障碍的药物研发方法:来自20年临床试验的启示

Horan, William P; Kalali, Amir; Brannan, Stephen K; Drevets, Wayne; Leoni, Matthew; Mahableshwarkar, Atul; Martin, William J; Rao, Srinivas; Reuteman-Fowler, Corey; Sauder, Colin; Savitz, Adam; Singh, Jaskaran; Tiller, Jane; Walker, Gary; Wendland, Jens R; Harvey, Philip D

Safety and efficacy with esketamine in treatment-resistant depression: long-term extension study

艾司氯胺酮治疗难治性抑郁症的安全性和有效性:长期扩展研究

Zaki, Naim; Chen, Li Nancy; Lane, Rosanne; Doherty, Teodora; Drevets, Wayne C; Morrison, Randall L; Sanacora, Gerard; Wilkinson, Samuel T; Young, Allan H; Lacerda, Acioly L T; Paik, Jong-Woo; Popova, Vanina; Fu, Dong-Jing

Solobacterium moorei sepsis secondary to flexor tenosynovitis: a case report and review of literature

屈肌腱鞘炎继发摩尔氏梭菌败血症:病例报告及文献综述

Popovic, Katarina; Arepalli, Satya Sai Venkata Lakshmi; Saju, Sachin; Drevets, Douglas

Efficacy and safety of aticaprant, a kappa receptor antagonist, adjunctive to oral SSRI/SNRI antidepressant in major depressive disorder: results of a phase 2 randomized, double-blind, placebo-controlled study

一项II期随机、双盲、安慰剂对照研究的结果显示,κ受体拮抗剂阿替卡仑作为口服SSRI/SNRI类抗抑郁药的辅助治疗,对重度抑郁症的疗效和安全性具有重要意义。

Schmidt, Mark E; Kezic, Iva; Popova, Vanina; Melkote, Rama; Van Der Ark, Peter; Pemberton, Darrel J; Mareels, Guy; Canuso, Carla M; Fava, Maurizio; Drevets, Wayne C